Ownership stake disclosure by BAKER BROS. ADVISORS LP (amended)
BAKER BROS. ADVISORS LP, filed by
KOD
Kodiak Sciences Inc. SEC filings
Every EDGAR filing for Kodiak Sciences Inc. (KOD), newest first, with AI summaries and stories.
- Ticker
- KOD
- CIK
- 1468748
- Sector
- Biotech and pharma
- Latest filing
- Sep 30
Next: earnings expected ~Nov 13 · 10-Q expected ~Nov 13 (deadline Nov 16)
Insider activity
- Director bought $52K
- Director bought $875K
- Director bought $102K
Also: 3 grants or exercises.
Filings
SCHEDULE 13D/AKodiak Sciences Inc.KODLIVE 4Kodiak Sciences Inc.KODLIVE 3 insider filings
Julian Baker, insider filing for KOD
Show all 3
- 4Insider filing for KOD
- 4Insider filing for KOD
- 4Insider filing for KOD
Julian Baker, reporting · Felix Baker, reporting · +4 more
4Kodiak Sciences Inc.KODLIVE Victor Perlroth, insider filing for KOD
Victor Perlroth, reporting
8-KKodiak Sciences Inc.KODLIVE SCHEDULE 13GKodiak Sciences Inc.KODLIVE Ownership stake disclosure by PRICE T ROWE ASSOCIATES INC /MD/
PRICE T ROWE ASSOCIATES INC /MD/, filed by
10-QKodiak Sciences Inc.KODLIVE 8-KKodiak Sciences Inc.KODLIVE 4Kodiak Sciences Inc.KODLIVE 2 insider filings
John A. Borgeson, insider filing for KOD
Show all 2
- 4Insider filing for KOD
- 4Insider filing for KOD
John A. Borgeson, reporting
4Kodiak Sciences Inc.KODLIVE 5 insider filings
Taiyin Yang, insider filing for KOD
Show all 5
- 4Insider filing for KOD
- 4Insider filing for KOD
- 4Insider filing for KOD
- 4Insider filing for KOD
- 4Insider filing for KOD
Taiyin Yang, reporting
4Kodiak Sciences Inc.KODLIVE Julian Baker, insider filing for KOD
Julian Baker, reporting · Felix Baker, reporting · +4 more
4Kodiak Sciences Inc.KODLIVE John A. Borgeson, insider filing for KOD
John A. Borgeson, reporting
8-KKodiak Sciences Inc.KODLIVE 144Kodiak Sciences Inc.KODLIVE John A. Borgeson, planned sale of KOD shares
John A. Borgeson, reporting
SCHEDULE 13GKodiak Sciences Inc.KODLIVE Ownership stake disclosure by Sirenia Capital Management LP
Sirenia Capital Management LP, filed by
10-QKodiak Sciences Inc.KODLIVE 8-KKodiak Sciences Inc.KODLIVE DEFA14AKodiak Sciences Inc.KODLIVE DEF 14AKodiak Sciences Inc.KODLIVE 4Kodiak Sciences Inc.KODLIVE John A. Borgeson, insider filing for KOD
John A. Borgeson, reporting
4Kodiak Sciences Inc.KODLIVE John A. Borgeson, insider filing for KOD
John A. Borgeson, reporting
144Kodiak Sciences Inc.KODLIVE John A. Borgeson, planned sale of KOD shares
John A. Borgeson, reporting
SCHEDULE 13GKodiak Sciences Inc.KODLIVE Ownership stake disclosure by Point72 Asset Management, L.P.
Point72 Asset Management, L.P., filed by
S-8Kodiak Sciences Inc.KODLIVE 10-KKodiak Sciences Inc.KODLIVE 8-KKodiak Sciences Inc.KODLIVE 4Kodiak Sciences Inc.KODLIVE Victor Perlroth, insider filing for KOD
Victor Perlroth, reporting
8-KKodiak Sciences Inc.KODLIVE 4Kodiak Sciences Inc.KODLIVE Victor Perlroth, insider filing for KOD
Victor Perlroth, reporting
SCHEDULE 13G/AKodiak Sciences Inc.KODLIVE 2 13G filings
Ownership stake disclosure by Point72 Asset Management, L.P. (amended)
Show all 2
- SCHEDULE 13G/AOwnership stake disclosure (amended)
- SCHEDULE 13G/AOwnership stake disclosure (amended)
Point72 Asset Management, L.P., filed by
5Kodiak Sciences Inc.KODLIVE Victor Perlroth, annual insider report for KOD
Victor Perlroth, reporting
SCHEDULE 13D/AKodiak Sciences Inc.KODLIVE Ownership stake disclosure by BAKER BROS. ADVISORS LP (amended)
BAKER BROS. ADVISORS LP, filed by
4Kodiak Sciences Inc.KODLIVE Julian Baker, insider filing for KOD
Julian Baker, reporting · Felix Baker, reporting · +4 more
8-KKodiak Sciences Inc.KODLIVE 424B5Kodiak Sciences Inc.KODLIVE 424B5Kodiak Sciences Inc.KODLIVE 10-QKodiak Sciences Inc.KODLIVE Kodiak Sciences Inc. (KOD) filed its Q3 2025 quarterly report (Form 10-Q), providing investors with an update on the company's financial performance and operational status.
8-KKodiak Sciences Inc.KODLIVE Kodiak Sciences Inc. (KOD) filed an 8-K report on November 13, 2025, disclosing the resignation of its Chief Executive Officer. This leadership change could have significant implications for the company's strategic direction and operations, and investors should closely monitor…